Exabis Library
Welcome to the e-CCO Library!
P003: C86/CD16 macrophages may act as a source of WNT2b in intestinal tissue from B3 Crohn’s disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P003: HDAC7 Controls Differentiation and Regeneration in the Intestinal Epithelium
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P003: Identification of a novel therapeutic agent for treating Crohn’s disease guided by systems medicine
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P003: Identification of an intestine-derived ex-Trm population in the blood of healthy individuals and patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P003: MicroRNAs as biomarkers in Inflammatory Bowel Disease unclassified (IBDU) patient samples may predict the development from IBDU to Crohn's Disease or Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P004 PN-943, an oral α4β7 integrin antagonist, inhibits MAdCAM1-mediated proliferation and cytokine release from CD4+ T cells independent of trafficking
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P004: Altered colonic mucosal oxylipins and endocannabinoids levels in treatment-naive and deep remission ulcerative colitis patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P004: Critical paralog proteins has a cell-type specific rewiring role in Ulcerative Colitis associated signalling processes
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P004: Exon-level microarrays identify alternative splicing for ICAM3 in Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P004: IL-22 affects barrier function and cell polarity by MAPK/PI3 kinase signal transduction
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P004: Microbiota, not host origin drives ex vivo epithelial response in ulcerative colitis patients and non-IBD controls.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P004: Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P004: Untargeted serum metabolome shows Crohn Disease (CD) associated signature, signals that correlate with disease activity and CRP, and signals that may precede disease flare
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P005 Regulators of the guanylate cyclase pathway are potential novel markers of mucosal healing in IBD
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P005: A multi-marker serum test to assess the presence of ulcerations in infliximab treated patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P005: Cytokine mediated intercellular communication in inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P005: Establishing a porcine model to translate anorectal stem cell organoid models to elucidate the aetiology of perianal Crohn's fistulae
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P005: Molecular-based classification of ulcerative colitis and its dynamic
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P005: Persistent transcriptional reprogramming in the choroid plexus during chronic colitis: towards understanding persistent fatigue in patients with quiescent inflammatory bowel disease?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P005: The solute carrier LC22A4/Organic Cation Transporter (OCTN)-1 as a novel Inflammatory Bowel Disease determinant at the microbe-host interface.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM